2019-2027| Vaccines Market | Top key Players, Size, Share, Applications|

Meticulous Research- leading global market research company published a research report titled "Vaccines Market by Indication (Influenza, Rotavirus, DTP Vaccines), Route of Administration (Intramuscular, Subcutaneous, Oral), Type/Antigen (Conjugate Vaccine, Live Attenuated Vaccine), Valence (Multivalent, Monovalent Vaccines) - Forecast to 2027".

According to this latest publication from Meticulous Research, the global vaccines market is expected to grow at a CAGR of 5.2% from 2019 to reach to $62.2 billion by 2027. The growth of the overall vaccines market is mainly attributed to the strong pipeline for vaccines, increasing government focus on immunization programs, and technological progress in vaccine administration. Increasing epidemic potentials, growing focus on therapeutic vaccines, and emerging markets offer significant growth opportunities for the players operating in this market. However, longer timelines and high cost of vaccines development are the key factors expected to hinder the adoption of vaccines over the coming years.

Download Sample Copy of Report @ http://bit.ly/2vaFQfR

On the basis of indication, the pneumococcal disease segment accounted for the largest share of the overall vaccines market in 2019. The large share of this segment is mainly attributed to the factors such as rising incidence of pneumococcal diseases like pneumonia, meningitis, febrile bacteraemia, otitis media, and initiatives by government organizations and private sectors to prevent and control outbreak of pneumococcal diseases. On the other hand, human papilloma virus segment is slated to grow at fastest CAGR due to increasing incidences for cervical cancers, high demand from emerging economies, and improvement in vaccination coverage rates for HPV.

On the basis of route of administration of vaccines, intramuscular route accounted for the largest share of the overall vaccines market in 2019 due to its easy accessibility, unaided administration, larger muscle capacity, and precise control of dose and administration rate. On the other hand, subcutaneous vaccines segment is slated to grow at the fastest CAGR mainly due to elicitation of better immune response and sustained absorption with high effectivity.

On the basis of antigen, subunit or conjugate vaccines segment accounted for the largest share of the overall vaccines market in 2019. Low risk of disease occurrence, long-term immunity, and high stability as compared to other antigens are the major factors attributing to the largest share of subunit vaccines market. On the other hand, inactivated vaccines are slated to grow at the fastest CAGR due to their non-infectious nature, can be given to immunocompromised patients, and ease in storage.

On the basis of valence, multivalent vaccines segment accounted for the largest share of the overall vaccines market in 2019 and is slated to grow at the fastest CAGR during the forecast period. New product launches and increasing focus and investment of key players to produce multivalent vaccines are the key factors attributing to the largest share of multivalent vaccines.

Read the full Research Report Study @ http://bit.ly/2RXAQEv

This research report analyzes major geographies and provides comprehensive analysis for North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, and RoAPAC), Latin America, and the Middle East & Africa. North America commanded the largest share of the global vaccines market in 2019, followed by Europe and Asia Pacific. The increasing efforts by the governments and companies to mandate vaccination in the North American region as well development of new vaccines is accelerating the vaccines market in the North American region. However, Asia Pacific region is expected to grow at the fastest CAGR during the forecast period due to large population of patients, establishment of vaccine production facilities, and increasing investments by the major players in this region. In addition, increasing disposable income and growing awareness about health in emerging countries further support the market growth.

The key players operating in the global vaccines market are Sanofi (France), Merck & Co., Inc. (U.S.), GlaxoSmithKline plc (U.K.), Pfizer Inc. (U.S.), Johnson & Johnson (U.S.), Daiichi Sankyo Co., Ltd. (Japan), Takeda Pharmaceutical Company Limited (Japan), CSL Limited (Australia), Emergent BioSolutions Inc. (U.S.), and AstraZeneca (U.K.) among others.

TOP 10 VACCINES MANUFACTURERS 2019 @ http://bit.ly/2S0JBh0

Key questions answered in the report-

Which are the high growth market segments on the basis of indication, route of administration, type/antigen, valence, and region/countries?
What was the historical market for vaccines across the globe?
What are the market forecasts and estimates for the period 2019-2027?
What are the major drivers, restraints, opportunities, and challenges in the global vaccines market?
Who are the major players in the vaccines market?
How is the competitive landscape and who are the market leaders in the global vaccines market?
What are the recent developments in the global vaccines market?
What are the different strategies adopted by the major players in the vaccines market?
What are the geographical trends and high growth regions/ countries?

Additional Insights-

In addition to global opportunity analysis and market forecasts, the Vaccines Market study provides detailed insights on regulatory analysis, product pipeline analysis, pricing analysis, and unmet need analysis. The study also showcases competitive benchmarking for top market players, by product and geography. The competitive landscape of this study also provides market share analysis, by market players and vaccines brand.

Click Here To Get Your Free Sample Report Now! @ http://bit.ly/2vaFQfR

Connect with us

Asia-Pacific
Office No-202, 203,204,205,206;
2nd Floor, Pushpak Business Hub,
Wakad, Pimpri-Chinchwad,
411057, India.
For Sales Enquires
India: +91-744-7780008
U.S.: +1-646-781-8004
U.K.: +44-203-868-8738

About Meticulous Research

The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze and present the critical market data with great attention to details.

Meticulous Research was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, with the help of its unique research methodologies, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa regions.

This release was published on openPR.